{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:59:52Z","timestamp":1790211592818,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/gme.0b013e31816665a7","type":"journal-article","created":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T03:20:54Z","timestamp":1220930454000},"page":"934-939","source":"Crossref","is-referenced-by-count":15,"title":["Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women"],"prefix":"10.1097","volume":"15","author":[{"given":"Iraj","family":"Nabipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeideh","family":"Beigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mojtaba","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Assadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raha","family":"Pazoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Sanjdideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210227","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1530\/eje.1.01874","article-title":"GH\/IGF-I and bone resorption in vivo and in vitro.","volume":"152","author":"Ueland","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R2-21-20210227","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/edrv.22.1.0419","article-title":"The somatomedin hypothesis.","volume":"22","author":"LeRoith","year":"2001","journal-title":"Endocr Rev"},{"key":"R3-21-20210227","doi-asserted-by":"crossref","first-page":"657","DOI":"10.33549\/physiolres.930307","article-title":"Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism.","volume":"52","author":"Zofkova","year":"2003","journal-title":"Physiol Res"},{"key":"R4-21-20210227","first-page":"1496","article-title":"One year of insulin-like growth factor I treatment dose not affect bone density, body composition, or psychological measures in postmenopausal women.","volume":"86","author":"Friedlander","year":"2001","journal-title":"JClin Endocrinol Metab"},{"key":"R5-21-20210227","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1359\/jbmr.1997.12.8.1272","article-title":"Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.","volume":"12","author":"Sugimoto","year":"1997","journal-title":"JBone Miner Res"},{"key":"R6-21-20210227","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1185\/030079905X49635","article-title":"Clinical use of serum and urine bone markers in the management of osteoporosis.","volume":"21","author":"Srivastava","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R7-21-20210227","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1359\/jbmr.1997.12.8.1272","article-title":"Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.","volume":"12","author":"Sugimoto","year":"1997","journal-title":"JBone Miner Res"},{"key":"R8-21-20210227","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2265.2001.01390.x","article-title":"The contribution of IGF-I to skeletal integrity in postmenopausal women.","volume":"55","author":"Munoz-Torres","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R9-21-20210227","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2265.1999.00776.x","article-title":"Postmenopausal osteoporosis is more related to hormonal aberrations than to lifestyle factors.","volume":"51","author":"Landin-Wilhelmsen","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R10-21-20210227","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2265.1999.00769.x","article-title":"The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.","volume":"51","author":"Kim","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R11-21-20210227","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s001980170075","article-title":"Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.","volume":"12","author":"Nakaoka","year":"2001","journal-title":"Osteoporos Int"},{"key":"R12-21-20210227","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00223-005-0163-z","article-title":"Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.","volume":"78","author":"Yamaguchi","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"R13-21-20210227","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S8756-3282(98)00066-0","article-title":"Insulin-like growth factor-I and bone mineral density.","volume":"23","author":"Collins","year":"1998","journal-title":"Bone"},{"key":"R14-21-20210227","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2265.1994.tb03018.x","article-title":"Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men.","volume":"40","author":"Rudman","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R15-21-20210227","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1210\/jcem-59-4-701","article-title":"Insulin-like growth factors I and II: aging and bone density in women.","volume":"59","author":"Bennett","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-21-20210227","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.55.12.870","article-title":"Relation between insulin-like growth factor-1 concentration, osteoarthritis, bone density, and fractures in the general population: the Chinford study.","volume":"55","author":"Lloyd","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"R17-21-20210227","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2265.2001.01278.x","article-title":"Low serum concentrations of insulin-like growth factor I are associated with femoral bone loss in a population-based sample of postmenopausal women.","volume":"55","author":"Seck","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R18-21-20210227","first-page":"4257","article-title":"Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study.","volume":"83","author":"Langlois","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-21-20210227","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1359\/jbmr.1998.13.8.1343","article-title":"Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study.","volume":"13","author":"Barrett-Connor","year":"1998","journal-title":"J Bone Miner Res"},{"key":"R20-21-20210227","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00198-007-0463-4","article-title":"The role of IGF-I and IGFBP-1 status and secondary hyperparathyroidism in relation to osteoporosis in elderly Swedish women.","volume":"19","author":"Salminen","year":"2007","journal-title":"Osteoporos Int"},{"key":"R21-21-20210227","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jocd.2006.05.001","article-title":"Peak bone mass of Iranian population: the Iranian Multicenter Osteoporosis Study.","volume":"9","author":"Larijani","year":"2006","journal-title":"J Clin Densitom"},{"key":"R22-21-20210227","doi-asserted-by":"crossref","first-page":"M516","DOI":"10.1093\/gerona\/55.9.M516","article-title":"Body composition, sex steroids, IGF-I, and bone mineral status in aging men.","volume":"55","author":"Ravaglia","year":"2000","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R23-21-20210227","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(99)05463-X","article-title":"Low serum IGF-I and occurrence of osteoporotic fractures in postmenopausal women.","volume":"355","author":"Garnero","year":"2000","journal-title":"Lancet"},{"key":"R24-21-20210227","first-page":"2286","article-title":"Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.","volume":"84","author":"Vestergaard","year":"1999","journal-title":"JClin Endocrinol Metab"},{"key":"R25-21-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3181\/00379727-219-44310","article-title":"Insulin-like growth factors and bone: the osteoporosis connection revisited.","volume":"219","author":"Donahue","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"issue":"2Suppl","key":"R26-21-20210227","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1016\/8756-3282(95)00186-H","article-title":"The insulin-like growth factor system and the coupling of formation to resorption.","volume":"17","author":"Hayden","year":"1995","journal-title":"Bone"},{"key":"R28-21-20210227","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/153537020322800302","article-title":"From mouse to man: redefining the role of insulin-like growth factor-I in the acquisition of bone mass.","volume":"228","author":"Yakar","year":"2003","journal-title":"Exp Biol Med"},{"key":"R29-21-20210227","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1073\/pnas.96.13.7324","article-title":"Normal growth and development in the absence of hepatic insulin-like growth factor I.","volume":"96","author":"Yakar","year":"1999","journal-title":"Proc Natl Acad Sci US A"},{"key":"R27-21-20210227","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI0215463","article-title":"Circulating levels of IGF-I directly regulate bone growth and density.","volume":"110","author":"Yakar","year":"2002","journal-title":"J Clin Invest"},{"key":"R30-21-20210227","first-page":"333","article-title":"Molecular basis and clinical application of biological markers of bone turnover.","volume":"17","author":"Calvo","year":"1996","journal-title":"Endocr Rev"},{"key":"R31-21-20210227","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1359\/jbmr.1999.14.7.1182","article-title":"Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.","volume":"14","author":"Murphy","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"R32-21-20210227","first-page":"8","article-title":"Insulin-like growth factor I levels in healthy adults.","volume":"62","author":"Landin-Wilhelmsen","year":"2004","journal-title":"Horm Res"},{"key":"R33-21-20210227","first-page":"1384","article-title":"Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women.","volume":"77","author":"Ebeling","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-21-20210227","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1172\/JCI118137","article-title":"Effects of rhIGF-I administration on bone turnover during short-term fasting.","volume":"96","author":"Grinspoon","year":"1995","journal-title":"J Clin Invest"},{"key":"R35-21-20210227","first-page":"44","article-title":"Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis.","volume":"81","author":"Johansson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 6","key":"R36-21-20210227","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s001980070002","article-title":"A position paper on the use of biochemical markers of bone turnover in osteoporosis.","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos Int"},{"key":"R37-21-20210227","first-page":"1046","article-title":"Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.","volume":"77","author":"Garnero","year":"1993","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/gme.0b013e31816665a7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:43Z","timestamp":1786036063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200815050-00021"}},"subtitle":["a population-based study"],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31816665a7","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}